Patent intelligence · US
US 9827268
Curable calcium phosphate composition for biological hard tissue repair, bone repair material, and various dental materials
Curable calcium phosphate composition for biological hard tissue repair, bone repair material, and various dental materials
Patent details — US 9827268
- Jurisdiction
- US
- Status
- granted
- Grant date
- Nov 28, 2017
- Expiration
- Nov 23, 2037
- Applicant
- KURARAY NORITAKE DENTAL INC.
- Claims
- 14
- CPC classes
- A61K, A61K33/10, A61K33/42, A61K6/00
Quick answer
US 9827268 (Curable calcium phosphate composition for biological hard tissue repair, bone repair material, and various dental materials) is held by KURARAY NORITAKE DENTAL INC.. Status: granted. Granted Nov 28, 2017. Expires Nov 23, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- KURARAY NORITAKE DENTAL INC.
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K33/10, A61K33/42, A61K6/00, A61K6/20, A61K6/54
More from KURARAY NORITAKE DENTAL INC.
Related pharmaceutical patents in our USPTO index.
-
US 12410184
Crystalline forms of a menin inhibitor
granted -
US 12377026
Dental adhesive material kit
granted -
US 12358210
Resin composition for stereolithography
granted -
US 12344691
Resin composition for stereolithography
granted -
US 12214061
Adhesive composition for dental use
granted -
US 12208148
Dental restorative curable composition
granted -
US 12145888
Zirconia molded body and pre-sintered body capable of being sintered in short time
granted -
US 12138325
Dental composition
granted
Frequently asked questions
What is US patent 9827268?
US 9827268 (Curable calcium phosphate composition for biological hard tissue repair, bone repair material, and various dental materials) is held by KURARAY NORITAKE DENTAL INC.. Status: granted. Granted Nov 28, 2017. Expires Nov 23, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9827268?
KURARAY NORITAKE DENTAL INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 132 pharmaceutical patents for this assignee.
When does US 9827268 expire?
Our index shows an expiration date of Nov 23, 2037 (11 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.